In experiments in dogs on the metabolic effects of inhalation anaesthetics, we noticed that in the presence of desflurane, oxygen uptake (VO 2 ) measured with the DeltatracII metabolic monitor seemingly increased whereas it decreased when determined independently by the Fick principle. This difference remained even after correction for changes in gas concentration on addition of an inhalation anaesthetic. Therefore, we suspected that desflurane interferes with the measurement of gas concentrations. Using different precision gases, we found that desflurane disturbed both the paramagnetic oxygen sensor and the infrared carbon dioxide detector so that the measured oxygen (when 2 , was 90.21) and carbon dioxide concentrations were greater than expected. These errors multiply in the computing process of oxygen uptake by the DeltatracII. When the DeltatracII is to be used during inhalation anaesthesia, its results should be corrected for the presence of an anaesthetic gas. More importantly, corrections must also be made for measurement errors of the oxygen and carbon dioxide sensors, unless the device has been equipped with a modified (nickel membrane) oxygen sensor insensitive to the presence of volatile agents. (Br.
We would like to draw attention to a source of error in the measurement of oxygen and carbon dioxide concentrations in the presence of inhalation anaesthetics in one particular analyser. The problem arose in experiments on the metabolic effects of desflurane in dogs. Using the DeltatracII metabolic monitor (Datex Instrumentation Corp., Helsinki, Finland) we noticed that both oxygen uptake 2 O ) (V ! and carbon dioxide production 2 CO ) (V ! seemingly increased with increasing desflurane concentration whereas it decreased with other inhalation anaesthetics. This overt discrepancy was also surprising because cardiac output markedly decreased in association with only a slight increase in the arteriovenous oxygen content difference, regardless of the anaesthetic used, that is even in the presence of desflurane. To resolve these contradictory observations, we determined V ! values were markedly lower than those measured by the DeltatracII, even after correction of the latter for dilution of the respiratory gases on addition of desflurane. 1 Hence the large concentrations of desflurane (MAC 6-7%) used for anaesthesia 2 and the subsequent greater inspiratory-expiratory desflurane difference alone did not entirely explain this considerable discrepancy. Therefore, we suspected that desflurane was causing an error in the measurement of gas concentrations, most likely by interfering with either the paramagnetic oxygen sensor (OM-101, Datex) or the infrared absorption carbon dioxide detector (CX-104, Datex), or both, used in the DeltatracII. This led us to evaluate the effects of desflurane on the measurement behaviour of both sensors in the presence of precision gases containing different concentrations of oxygen, carbon dioxide, or both.
Materials and methods
The DeltatracII is an open circuit indirect calorimeter using a gas dilution principle for determining respiratory gas volumes required for gas exchange measurements. 3 The paramagnetic oxygen sensor measures the difference in oxygen concentrations between inlet I (alternating inspired gas or room air) and inlet II (mixed expired gas) ( fig. 1A ). (Note that the microphone membrane of the differential oxygen sensor is made of plastic and covered with a metal layer (gold) at inlet I.) Unlike in standard gas analysers, in which the plastic surface of the sensor membrane (at inlet II) is exposed exclusively to air ( fig.  1C ), volatile anaesthetics may reach both sides of the sensor membrane in the DeltatracII ( fig. 1A, B) and thus affect its sensitivity.
Before each experiment, the gas sensors were calibrated with a high precision gas (5.00<0.03% carbon dioxide-balance oxygen; Messer Griesheim, Duisburg, Germany) and the ) through the inspiratory port of the DeltatracII (inlet I) to the metallized side of the sensor membrane. The same gases, after equilibration with 0, 7 and 14 vol.% desflurane (vaporizer Tec 6, Ohmeda, Steeton, UK), were fed to the mixing chamber of the DeltatracII (at a flow of 2 litre min
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) from where samples were sucked to the plastic side of the sensor membrane (via inlet II). In this way it was possible to recognize if the presence of desflurane at the plastic side of the oxygen sensor membrane (via inlet II) would disturb the oxygen concentration measurement of the inspiratory gas sample (inlet I). Desflurane concentrations were monitored continuously by infrared spectroscopy (Capnomac Ultima SV multi-gas analyser, Datex).
Results
With the sensor membrane exposed to desflurane via inlet II, the DeltatracII measured erroneously large oxygen concentrations of the inspiratory gas sample. This is shown by the relations between oxygen concentrations in the precision gases and those measured by the DeltatracII in figure 2A . As expected, in the absence of desflurane, the data points fell almost on the line of identity, indicating that the DeltatracII measured oxygen concentrations correctly in these circumstances. However, in the presence of desflurane at inlet II, the DeltatracII measured the oxygen differentials (i.e. O 2 sample gas 9O 2 Air ) correctly only with room air as a carrier gas but gave higher readings when the oxygen concentrations increased at inlet I. As a result, the relationships between measured and expected oxygen differentials retained their linearity but were tilted anti-clockwise ( fig. 2A ). While the intercepts of these relationships were negligible (0.2 for each curve), their slopes increased from 0.97 to 1.07 and 1.23 (at 0, 7 and 14 vol.% desflurane), and could be related, by first approximation, to the fractions of desflurane (F Desfl ) (see inset in fig. 2A ): slope : 1;1.9 F Desfl .
Hence, it was possible to correct the oxygen measurements for this error: Figure 2 Effects of desflurane on measurements of oxygen concentrations. In A, measured oxygen concentrations deviated from those in the precision gases at larger oxygen and desflurane concentrations. Note that oxygen concentrations are measured against room air so that the difference becomes 0 when air is used as a carrier gas. The inset shows that the slopes of the resulting curves can be related linearly to desflurane concentrations, which alleviates correction. In B, the DeltatracII readings of ⌬O 2 (i.e. oxygen concentration difference over the sensor membrane, inlet I vs II) were greater (19% on average) than expected in the presence of desflurane. The broken lines indicate identity. 
Although of less importance, desflurane also disturbed the infrared carbon dioxide sensor. On addition of desflurane (5, 10, and 15 vol.%), measured carbon dioxide concentrations were 4.2, 7.8 and 10.4% greater than those calculated using a precision gas containing 5.00 < 0.03% carbon dioxide-19% oxygen-76% nitrogen. Thus the gain error (% change in the ratio of measured and calculated values) increased linearly with desflurane fractions ( fig. 3) V ! measurements by the Fick principle were used as a reference, we took care to measure as accurately as possible both the arteriovenous oxygen content difference and cardiac output. Arterial (carotid artery) and mixed venous blood (pulmonary artery) were sampled simultaneously in air-free syringes and the total oxygen content in blood measured immediately in duplicate (Lex O 2 Con, Lexington Instr., Waltham, MA, USA).
Cardiac output (i.e. pulmonary blood flow) was measured continuously (beat by beat) with ultrasonic transit-time flow probes (Transonic, Ithaka, NY, USA) chronically implanted around the pulmonary artery (after approval by the local District Government) and averaged over the entire blood sampling period.
For every measurement, we calculated the worst case error according to the law of error propagation: the accuracy of the oxygen content analyser is <1% for a single measurement and <0.75% for the mean of two measurements. Hence the 95% confidence interval for an arterial or mixed-venous sample is within <1.5% (<2 SD) of the measured value and the error of the calculated arteriovenous oxygen content difference sums up to 6% (2 3%).
The accuracy of the ultrasound transit-time flowmeter is <7.5% for a single stroke volume but improves to <1.2% V ! values obtained by the DeltatracII. Of note, lung oxygen consumption, which is not detected by the Fick measurement but is detected with the DeltatracII, is less than 5% of total 2 O V ! and thus negligible in healthy dogs and humans. 4 5 
Discussion
Desflurane disturbed, in a concentration-dependent manner, measurements of oxygen and carbon dioxide concentrations in the DeltatracII metabolic monitor. As a consequence, the oxygen concentration differences across the sensor membrane (inspiratory to expiratory ⌬O 2 ) were overestimated by approximately 20% in the presence of desflurane. As ⌬O 2 is a dominant factor in the computation of V ! values which were up to 1.7 times greater than expected (Fick principle) (table 1) if no corrections were applied. Hence the DeltatracII readings must be corrected for both the addition of desflurane (which alters respiratory gas concentrations) and also for the error in the measurement of gas concentrations. The correction for the first problem according to Aukburg The measurement errors of the gas sensors are not unique to desflurane, as we have found that other inhalation anaesthetics disturbed the oxygen and carbon dioxide detectors in a similar manner (data not shown). Yet because of the smaller concentrations used for anaesthesia, impairment of gas concentration measurements matters little for the computation of 2 O . V ! Interference of volatile anaesthetics with carbon dioxide detectors has been reported previously, 6 the underlying mechanism being deformation of the infrared carbon dioxide absorption peak by collision of carbon dioxide with other gas molecules. 7 However, this carbon dioxide measurement error is of minor relevance for calculation of We have shown for the first time that volatile anaesthetics (which are non-paramagnetic molecules) also disturb the paramagnetic oxygen sensor. The culprit for this error seems to be the plastic surface which alters the sensitivity of the microphone membrane of the differential oxygen sensor either by deformation of its thickness (swelling) or change of its dielectric constant as desflurane is absorbed. Consistent with this view, replacing the plastic membrane by one made from nickel almost completely eliminated the oxygen measurement error induced by desflurane (data not shown). Standard gas monitors which use the same gas sensors (e.g. the Capnomac Ultima, Datex) were not affected by desflurane because the plastic surface of its microphone membrane is always exposed to room air thus preventing contact with volatile agents (fig. 1C) .
Of note, the DeltatracII metabolic monitor has not been designed for metabolic studies during inhalation anaesthesia. Nevertheless, it can be used for this purpose when the appropriate corrections are made for the changes in respiratory gas concentrations by additional gases and, in particular, for the effects of inhalation anaesthetics on the measurement of gas concentrations, as we have shown. Another option would be to use gas sensors which are not disturbed by volatile anaesthetics. Such modified sensors will be available soon as spare parts for the DeltatracII metabolic monitor. The new version of the paramagnetic oxygen sensor of the Datex-Engstrom, 8 as implemented in the compact gas exchange module M-COVX of the Datex AS/3 monitor system, is equipped with a nickel film microphone membrane and therefore is immune to volatile anaesthetic agents.
It should be noted that the DeltatracII cannot be used during anaesthesia with nitrous oxide instead of nitrogen. In this case, the Haldane transformation used to derive inspired from expired tidal volumes does not apply because of the different uptake kinetics of nitrous oxide. Furthermore, it should be remembered that our corrections apply to steady state conditions rather than to rapidly changing gas concentrations, and that different gas sensors may require an individual check of its correction factors. Finally, it is a pleasing result that oxygen uptake, when determined correctly, does not increase, but rather decreases in the presence of desflurane, in common with other inhalation anaesthetics. 
